Swiss Pharma Co. Shakes Suit Over $120M Supply Contract

Law360, Los Angeles (January 17, 2013, 6:06 PM EST) -- A New York federal judge on Wednesday ruled in favor of Ed. Geistlich Soehne AG in a dispute with Luitpold Pharmaceuticals Inc. over its $120 million licensing and distribution agreements for dental products, finding the Swiss chemical and pharmaceutical conglomerate had the right to terminate the contract for "any reason whatsoever."

Luitpold in 2011 sued Geistlich for breach of contract and related claims, accusing the company of wasting the money Luitpold spent developing a market for Geistlich's regenerative dental products in the U.S., Mexico, the Caribbean,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.